nifedipine has been researched along with doxazosin in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.70) | 18.7374 |
| 1990's | 12 (44.44) | 18.2507 |
| 2000's | 7 (25.93) | 29.6817 |
| 2010's | 6 (22.22) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Sen, S; Sinha, N | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Donnelly, R; Elliott, HL; Howie, CA; Meredith, PA; Reid, JL | 2 |
| Donnelly, R; Elliott, HL; Howie, CA; Reid, JL; Sumner, DJ | 1 |
| Donnelly, R; Elliott, HL; Meredith, PA; Reid, JL | 1 |
| Alabaster, VA; Solca, AM | 1 |
| Canessa, ML; DeFronzo, RA; Giordano, M; Matsuda, M; Sanders, L | 1 |
| Canessa, ML; Castellino, P; DeFronzo, RA; Giordano, M; Sanders, LR | 1 |
| Alarayyed, NA; Betteridge, DJ; Cooper, MB; Prichard, BN; Smith, CC | 1 |
| Canessa, ML; Castellino, P; DeFronzo, RA; Giordano, M; Solini, A | 1 |
| Iversen, BM; Kvam, FI; Ofstad, J | 1 |
| Bialy-Golan, A; Brenner, S; Shachar, E; Srebrnik, A | 1 |
| Beaman, M; D'Souza, RJ; Hamilton-Wood, C; Nicholls, AJ; Pearson, ER | 1 |
| Hughes, PL; Oo, T; Soni, BM; Vaidyanathan, S | 1 |
| Kompaniets, OG; Pokrovskii, VM | 1 |
| Eto, M; Fukagawa, A; Imanishi, A; Latifpour, J; Yamamoto, Y; Yono, M; Yoshida, M | 2 |
| Caça, I; Cınar, Y; Mehmet Türkcü, F; Sahin, A; Yıldırım, A; Yüksel, H | 1 |
| Cang, H; Gong, Y; He, M; Li, Y; Liang, D; Liu, G; Pan, Y; Shi, J; Wang, W; Zhang, H; Zhang, S | 1 |
| De Angelis, MV; Di Stefano, V; Onofrj, M; Rispoli, MG | 1 |
2 review(s) available for nifedipine and doxazosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New drugs for hypertension--variations on old themes.
Topics: Amlodipine; Antihypertensive Agents; Delayed-Action Preparations; Dihydropyridines; Doxazosin; Humans; Hypertension; Isradipine; Nifedipine; Prazosin; Verapamil | 1991 |
7 trial(s) available for nifedipine and doxazosin
| Article | Year |
|---|---|
Vascular pressor responses in treated and untreated essential hypertension.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Antihypertensive Agents; Blood Pressure; Catecholamines; Doxazosin; Enalapril; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Peptidyl-Dipeptidase A; Phenylephrine; Prazosin; Reflex; Regional Blood Flow; Renin | 1990 |
Dose-response clarification in early drug development.
Topics: Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Doxazosin; Enalapril; Humans; Hypertension; Nifedipine; Prazosin | 1991 |
The pharmacodynamics and pharmacokinetics of the combination of nifedipine and doxazosin.
Topics: Adult; Blood Pressure; Doxazosin; Drug Therapy, Combination; Heart Rate; Humans; Liver Circulation; Male; Nifedipine; Single-Blind Method | 1993 |
Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients.
Topics: Adrenergic alpha-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Type 2; Doxazosin; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hypertension; Kidney; Kidney Function Tests; Male; Middle Aged; Nifedipine; Proteinuria | 1996 |
Na+/Li+ and Na+/H+ countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and antihypertensive treatment.
Topics: Adult; Antihypertensive Agents; Antiporters; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Doxazosin; Erythrocytes; Female; Glucose; Glucose Clamp Technique; Humans; Hypertension; Insulin; Lithium; Male; Middle Aged; Nifedipine; Sodium; Sodium-Hydrogen Exchangers; Triglycerides | 1997 |
Assessment of therapeutic drug efficiency.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Doxazosin; Heart Rate; Humans; Nifedipine; Treatment Outcome | 2008 |
Effects of doxazosin mesylate versus nifedipine on blood pressure variability in hypertensive patients: a randomized crossover study (SIMILAR).
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Doxazosin; Essential Hypertension; Female; Humans; Male; Middle Aged; Nifedipine; Young Adult | 2019 |
18 other study(ies) available for nifedipine and doxazosin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Combination of nifedipine and doxazosin in essential hypertension.
Topics: Aged; Analysis of Variance; Angiotensin II; Antihypertensive Agents; Blood Pressure; Doxazosin; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Phenylephrine; Prazosin | 1992 |
Lack of differential inhibition by nifedipine of pressor responses induced by alpha 1- and alpha 2-adrenoceptor agonists and by angiotensin II in anaesthetized cats.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Blood Pressure; Cats; Doxazosin; Male; Muscle, Smooth, Vascular; Nifedipine; Nordefrin; Phenylephrine; Prazosin; Vasoconstriction; Yohimbine | 1985 |
Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
Topics: Adrenergic alpha-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Captopril; Cholesterol; Diabetes Mellitus, Type 2; Doxazosin; Fatty Acids, Nonesterified; Female; Glucose; Glycated Hemoglobin; Humans; Hypertension; Insulin; Lipid Metabolism; Lipids; Male; Middle Aged; Nifedipine | 1995 |
In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Aequorin; Analysis of Variance; Blood Platelets; Calcium; Calcium Channel Blockers; Collagen; Dose-Response Relationship, Drug; Doxazosin; Drug Interactions; Epinephrine; Fibrinogen; Humans; In Vitro Techniques; Luminescent Measurements; Middle Aged; Naphthalenes; Nifedipine; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors | 1997 |
Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Capillaries; Doxazosin; Enalapril; Homeostasis; Hypertension; Kidney; Kidney Glomerulus; Male; Nifedipine; Rats; Rats, Inbred SHR; Regional Blood Flow; Renal Circulation; Verapamil | 1998 |
"Two-step" drug-induced bullous pemphigoid.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Doxazosin; Female; Humans; Middle Aged; Nifedipine; Pemphigoid, Bullous | 1998 |
Hypertensive encephalopathy and nephrotic syndrome: a possible link?
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Azathioprine; Brain Diseases; Calcium Channel Blockers; Diuretics; Doxazosin; Female; Furosemide; Headache; Humans; Hypertension; Immunosuppressive Agents; Magnetic Resonance Imaging; Middle Aged; Nephrotic Syndrome; Nifedipine; Prednisolone; Seizures; Visual Acuity | 1999 |
Recurrent autonomic dysreflexia due to chronic aortic dissection in an adult male with cervical spinal cord injury.
Topics: Adrenergic alpha-Antagonists; Aortic Rupture; Autonomic Dysreflexia; Calcium Channel Blockers; Cervical Vertebrae; Chronic Disease; Doxazosin; Humans; Male; Middle Aged; Nifedipine; Recurrence; Spinal Cord Injuries | 2008 |
Molecular mechanisms regulating urogenital expression of nitric oxide synthase in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Animals; Calcium Channel Blockers; Doxazosin; Gene Expression; Gene Expression Profiling; Hypertension; Male; Nifedipine; Nitric Oxide Synthase; Oligonucleotide Array Sequence Analysis; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; Urogenital System | 2009 |
Identification of potential therapeutic targets in hypertension-associated bladder dysfunction.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Doxazosin; Gene Expression; Gene Expression Profiling; Hypertension; Male; Microarray Analysis; Nifedipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Urinary Bladder Diseases | 2010 |
Diagnosis of malignant hypertension with ocular examination: a child case.
Topics: Antihypertensive Agents; Blood Pressure; Child; Doxazosin; Drug Therapy, Combination; Enalapril; Female; Fluorescein Angiography; Humans; Hypertension, Malignant; Intraocular Pressure; Nifedipine; Papilledema; Retinal Hemorrhage; Tomography, Optical Coherence; Tonometry, Ocular; Vasodilator Agents; Vesico-Ureteral Reflux; Visual Acuity | 2014 |
Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement.
Topics: Antihypertensive Agents; Brain Stem; Calcium Channel Blockers; Diagnosis, Differential; Doxazosin; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nifedipine; Posterior Leukoencephalopathy Syndrome; Ramipril; White Matter | 2020 |